Chandana G. Lall MD, Presenter: Nothing to Disclose

Puneet Bhargava MD, Abstract Co-Author: Editor, Reed Elsevier

Temel Tirkes MD, Abstract Co-Author: Nothing to Disclose

Priya Ranjit Bhosale MD, Abstract Co-Author: Nothing to Disclose

Sadhna Verma MD, Abstract Co-Author: Nothing to Disclose

Joon-Il Choi, Abstract Co-Author: Nothing to Disclose

Martin Roberto Goyenechea MD, Abstract Co-Author: Nothing to Disclose

Alampady Krishna Prasad Shanbhogue MD, MBBS, Abstract Co-Author: Nothing to Disclose

Pathophysiology , Genetic and phenotypic expression of HCC Classic Imaging parameters that aid in making the diagnosis of HCC Atypical Imaging features; A guide to making the correct diagnosis Imaging features and their prognostic implications Role of ultra high B value DWI if any Brief overview of current treatment options in non transplant candidates  

CONTENT ORGANIZATION Demographics of HCC Role of Imaging; Classic and Atypical Imaging features of HCC on MRI and CT Genetics of HCC: Role for chemotherapy tailored to Genotype; Tumor markers in biphenotypic HCC. Progenitor cell markers including OATP, epiCAM, K7, K19 etc Prediction of tumor prognosis by imaging parameters: size, presence of a capsule, Early rim enhancement, intralesional fat, enhancement characteristics, TIWI characteristics, Eovist uptake, Halo or corona enhancement etc Treatment options: When, Why, How? TACE, TACE with drug eluting beads, Yttrium 90, Sorafenib  

http://abstract.rsna.org/uploads/2014/14012397/14012397_dti6.pdf

Lall, C, Bhargava, P, Tirkes, T, Bhosale, P, Verma, S, Choi, J, Goyenechea, M, Shanbhogue, A, HCC- A to Z: A Comprehensive Review and Synopsis of Hepatocellular Carcinoma—A One Stop Shop!.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14012397.html